Company
Sio Gene Therapies Inc. (0001636050)
Standardized SEC financial data for Sio Gene Therapies Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001636050 · Pharmaceutical Preparations.
Return on equity
-220.6%
Free cash flow
-$60.3M
Debt / equity
0.00×
Current ratio
5.52×
EPS (diluted)
$-0.98
Income statement
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| R&D expense | $134.8M | — | $87.6M | $47.1M | $24.9M | $53.4M |
| SG&A expense |
Balance sheet
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $212.6M | $154.3M | $107.0M | $80.8M | $120.2M | $64.9M |
| Total current assets |
Cash flow
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$112.1M | -$190.3M | -$134.2M | -$67.5M | -$46.6M | -$60.3M |
| Investing cash flow |
Get 0001636050 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001636050/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001636050/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"